fixx stock forecast

View all of FIXX's competitors. View real-time stock prices and stock quotes for a full financial overview. Homology Medicines's earnings in 2020 is -$124,465,000.On average, 4 Wall Street analysts forecast FIXX's earnings for 2020 to be $-142,083,009, with the lowest FIXX earnings fore Homology Medicines has received a consensus rating of Buy. Its lead product candidate is HMI-102, which is in Phase 1/2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. View insider buying and selling activity for Homology Medicines or view top insider-selling stocks. Homology Medicines trades on the NASDAQ under the ticker symbol "FIXX.". Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The consensus among Wall Street research analysts is that investors should "buy" Homology Medicines stock. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. See what's happening in the market right now with MarketBeat's real-time news feed. During that period the price should oscillate between -11.89% and +10.42%. Find real-time SFIX - Stitch Fix Inc stock quotes, company profile, news and forecasts from CNN Business. Homology Medicines' management team includes the following people: The firm that called the Exact Peak of the Dot-Com boom has just issued another major prediction. FIXX stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Sofinnova Investments Inc., BlackRock Inc., Vivo Capital LLC, Victory Capital Management Inc., Virtus ETF Advisers LLC, and WINTON GROUP Ltd. Company insiders that have sold Homology Medicines company stock in the last year include Albert Seymour, Arthur Tzianabos, James E Flynn, Kush Parmar, Timothy P Kelly, and W Bradford Smith. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. (Add your “outperform” vote. CNN Sans™ & © 2016 Cable News Network. 7 brokers have issued 12-month price objectives for Homology Medicines' stock. FIXX Stock Forecast and Score Homology Medicines Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Real-time trade and investing ideas on Homology Medicines FIXX from the largest community of traders and investors. View analyst ratings for Homology Medicines or view MarketBeat's top 5 stock picks. Homology Medicines had a negative net margin of 5,386.00% and a negative return on equity of 57.92%. Learn about financial terms, types of investments, trading strategies and more. FIXX Stock Forecast. High institutional ownership can be a signal of strong market trust in this company. What this means: InvestorsObserver gives Homology Medicines Inc (FIXX) an overall rank of 44, which is below average. Scan for strong stocks. Based on 3 analysts offering 12 month price targets for Homology Medicines in the last 3 months. The company earns $-103,920,000.00 in net income (profit) each year or ($2.47) on an earnings per share basis. Log In. Based on aggregate information from My MarketBeat watchlists, some companies that other Homology Medicines investors own include Editas Medicine (EDIT), Sorrento Therapeutics (SRNE), NVIDIA (NVDA), Gossamer Bio (GOSS), Spero Therapeutics (SPRO), Alector (ALEC), Dynavax Technologies (DVAX), Advanced Micro Devices (AMD), Canopy Growth (CGC) and Inovio Pharmaceuticals (INO). NASDAQ 0.00%. According to present data Stitch Fix Inc - Class A's SFIX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The FIXX stock will be analyzed using Smart Scan and the Trade Triangle technology. Should I buy or sell FIXX? Homology Medicines … Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. If we look at the company’s 10-day average daily trading volume, we find that it stood at 601.45 Million shares traded. View which stocks have been most impacted by COVID-19. Homology Medicines has only been the subject of 1 research reports in the past 90 days. Find out now. 78.39% of the stock of Homology Medicines is held by institutions. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. SONA FORECASTS. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The company can be reached via phone at 781-301-7277. View the latest Homology Medicines Inc. (FIXX) stock price, news, historical charts, analyst ratings and financial information from WSJ. View Homology Medicines, Inc. FIXX investment & stock information. DOW 0.00%. Get the latest Homology Medicines, Inc. FIXX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Homology Medicines Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Do Not Sell My Information. Get international weather forecasts from AccuWeather.com and display them in any toolbar or statusbar with this highly customizable and unobtrusive extension. All rights reserved. On average, they anticipate Homology Medicines' stock price to reach $30.43 in the next year. FIXX Stock Forecast - Get a free FIXX stock predictions and find out whether you should buy or sell FIXX stock. The official website for Homology Medicines is www.homologymedicines.com. Homology Medicines is scheduled to release their next quarterly earnings announcement on Monday, May 13th 2019. Factset: FactSet Research Systems Inc.2019. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Stitch Fix Inc - Class A share forecasts, stock quote and buy / sell signals below. Find out now with a free analysis on Homology Medicines. Rooms Rankings Earnings Calendar Shop. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. The trend analysis tool will help you make a better prediction on the FIXX stock. The company also develops HMI-103 for the treatment of PKU in pediatric patients; and HMI-202 to treat metachromatic leukodystrophy. View institutional ownership trends for Homology Medicines. View Homology Medicines' earnings history. Homology Medicines Inc () Stock Market info Recommendations: Buy or sell Homology Medicines stock? The average price target represents a … Vote “Outperform” if you believe FIXX will outperform the S&P 500 over the long term. Homology Medicines is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021. Analyst Price Target on FIXX. The company reported ($0.62) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.81) by $0.19. Homology Medicines, Inc. Stock Price Forecast, "FIXX" Predictons for2020 Stitch Fix Stock Jumped 160% in 2020 -- And It's Just Getting Started John Ballard | Dec 18, 2020 The personal styling service expects revenue growth to explode next year. Cancel. [Felix L.] - [Fixx] c/o Webmedia Gaming GmbH allyance Cuvrystr. FIXX Technical Analysis. Dividend. Learn more. What is Homology Medicines's current dividend yield, its reliability and sustainability? There are currently 7 buy ratings for the stock. Find real-time FIXX - Homology Medicines Inc stock quotes, company profile, news and forecasts from CNN Business. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The 3-month trading volume is 424.06 Million shares. Homology Medicines employs 206 workers across the globe. Should I buy FIXX stock? A Warner Media Company. Explore more healthy companies in the Pharmaceuticals & Biotech industry. Homology Medicines has received 102 “outperform” votes. BofA Merrill Lynch, Cowen and Evercore ISI served as the underwriters for the IPO and BTIG was co-manager. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and thirteen have given a buy rating to the stock. FIXX Stock Analysis Overview . Export data to Excel for your own analysis. SFIX | Complete Stitch Fix Inc. Cl A stock news by MarketWatch. Homology Medicines has a P/B Ratio of 2.15. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. FIXX Stock Analysis - [Full Report] Free Signup: Advanced stock screener. Homology Medicines does not currently pay a dividend. No recent news for Homology Medicines Inc. FIXX Stock Analysis Overview What this means: InvestorsObserver gives Homology Medicines Inc (FIXX) an overall rank of 42, which is below average. According to analysts' consensus price target of $30.43, Homology Medicines has a forecasted upside of 146.6% from its current price of $12.34. In the short term (2weeks), FIXX's stock price should underperform the market by -3.04%. Get daily stock ideas top-performing Wall Street analysts. Forecast Cash Runway: FIXX is forecast to have sufficient cash runway for 12 months based on free cash flow estimates, but has since raised additional capital. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View live HOMOLOGY MEDICINES INC chart to track its stock's price action. Some companies that are related to Homology Medicines include Myovant Sciences (MYOV), Seres Therapeutics (MCRB), Y-mAbs Therapeutics (YMAB), Zentalis Pharmaceuticals (ZNTL), Kura Oncology (KURA), Arcus Biosciences (RCUS), uniQure (QURE), NGM Biopharmaceuticals (NGM), Nkarta (NKTX), Harmony Biosciences (HRMY), Stoke Therapeutics (STOK), Kronos Bio (KRON), Cryoport (CYRX), Amarin (AMRN) and Ironwood Pharmaceuticals (IRWD). All rights reserved. AC Investment Inc. delivers machine learning based share price forecast. View Homology Medicines' (NASDAQ:FIXX) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. Our latest prediction for Homology Medicines, Inc.'s stock price was made on the Jan. 30, 2020 when the stock price was at 15.99$. Homology Medicines has received 51.00% “outperform” votes from our community. 100% FREE. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Never miss a profitable trade. Find the latest analyst research for Homology Medicines, Inc. Common Stock (FIXX) at Nasdaq.com. Homology Medicines, Inc. (NASDAQ:FIXX) announced its quarterly earnings results on Monday, November, 9th. Homology Medicines' stock is owned by a number of institutional and retail investors. FIXX Stock Predictions. FIXX | Complete Homology Medicines Inc. stock news by MarketWatch. Homology Medicines has a market capitalization of $564.89 million and generates $1.67 million in revenue each year. View our earnings forecast for Homology Medicines. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. All rights reserved. Homology Medicines Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 9.43% of US listed stocks. Stitch Fix's earnings in 2020 is -$57,398,000.On average, 9 Wall Street analysts forecast SFIX's earnings for 2021 to be $-25,838,548, with the lowest SFIX earnings forecast at $-45,879,585, and the highest SFIX earnings forecast at $2,085,436. FIXX stock was bought by a variety of institutional investors in the last quarter, including Vida Ventures Advisors LLC, JPMorgan Chase & Co., Morgan Stanley, Teachers Retirement System of The State of Kentucky, Charles Schwab Investment Management Inc., GSA Capital Partners LLP, ExodusPoint Capital Management LP, and DekaBank Deutsche Girozentrale. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. Real-time trade and investing ideas on Homology Medicines FIXX from the largest community of traders and investors. (Add your “underperform” vote.). (FIXX) raised $100 million in an initial public offering (IPO) on Wednesday, March 28th 2018. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Homology Medicines in the last year. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Stitch Fix has an average rating of “Hold” and a consensus target price of $63.52. This suggests a possible upside of 143.8% from the stock's current price. Shares of FIXX can be purchased through any online brokerage account. Next Steps . The P/E ratio of Homology Medicines is -4.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. FIXX Stock Predictions. The FIXX stock price is -80.43% off its 52-week high price of $22.5 and 30.23% above the 52-week low of $8.7. Find the latest Homology Medicines, Inc. (FIXX) stock quote, history, news and other vital information to help you with your stock trading and investing. Looking for new stock ideas? The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Trending now. Since then, FIXX shares have decreased by 30.3% and is now trading at $12.48. ST; Dec. 16, 2020 Price forecast | 2 weeks: -1.00% | 1 month: -1.64% | 3 months: -3.19%. Sign Up. © 2020 Cable News Network. FIXX Stock Summary. Their forecasts range from $27.00 to $34.00. Co-Founder & Chair of Scientific Advisory Board, Chief Communications Officer & Patient Advocate, Start Your Risk-Free Trial Subscription Here, Time to buy AT&T (NYSE: T) Stock on HBO Max DCEU Rollout, Last-Minute Stocking Stuffers For Dividend-Growth Investors, The Post-Earnings Dip in FedEx Stock Screams Buy, Vulcan Materials (NYSE: VMC): The Construction Company That's Hitting All Time Highs, Fortinet (NASDAQ: FTNT) Ready To Hit The Ground Running In January, Spotify’s (NYSE: SPOT) Expansion Shows No Signs of Slowing Down, Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors, Disney (NYSE: DIS) is Ready to Take on Netflix, 3 SPAC Stocks for Investors to Watch in 2021, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Stock analysis for Homology Medicines Inc (FIXX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the hottest stocks to trade every day before the market opens 100% free. BOSTON (AI Forecast Terminal) Thu, Oct 29, '20 AI Forecast today took the forecast actions: In the context of stock price realization of FIXX Homology Medicines is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast … FIXX Stock Forecast - Is FIXX a buy or sell? Homology Medicines does not have a long track record of dividend growth. Homology Medicines' stock was trading at $17.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Please log in to your account or sign up in order to add this asset to your watchlist. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Should I buy or sell FIXX? Most stock quote data provided by BATS. The FIXX stock forecast is provided by MarketClub with their Trade Triangle system. Specifically, they have bought $0.00 in company stock and sold $6,125,000.00 in company stock. Limited Time Only. Homology Medicines, Inc. Common Stock (FIXX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Only 28.00% of the stock of Homology Medicines is held by insiders. View which stocks are hot on social media with MarketBeat's trending stocks report. Click here now. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Learn everything you need to know about successful options trading with this three-part video course. View insider buying and selling activity for Homology Medicines or or view top insider-buying stocks. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings. The following FIXX technical analysis is based on short term price movement and trend analysis. MarketBeat just released five new trading ideas, but Homology Medicines wasn't one of them. Identify stocks that meet your criteria using seven unique stock screeners. All Rights Reserved. You may vote once every thirty days. Dividend Yield vs Market. In the past three months, Homology Medicines insiders have sold more of their company's stock than they have bought. View our full suite of financial calendars and market data tables, all for free. Find market predictions, FIXX financials and market news. Sign-up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. ), Homology Medicines has received 98 “underperform” votes. Homology Medicines Inc's stock had its IPO on March 28, 2018, making it an older stock than merely 7.99% of US equities in our set. To see all exchange delays and terms of use please see disclaimer. All times are ET. View real-time stock prices and stock quotes for a full financial overview. View analysts' price targets for Homology Medicines or view Wall Street analyst' top-rated stocks. Absolutely genius, this is how Americans without health insurance are getting help! II-VI Inc - IIVI Get email alerts Dec. 16, 2020 SELL. Wall Street analysts have given Homology Medicines a "Buy" rating, but there may be better short-term opportunities in the market. See Homology Medicines, Inc. (FIXX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View Homology Medicines' (NASDAQ:FIXX) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat. Receive a free world-class investing education from MarketBeat. Three months stock forecast Dec. 16, 2020. 3-4 10997 Berlin E-Mail: [email protected] Telefon: +49 (0) 89 244 136 705 Web: www.jointheallyance.de © American Consumer News, LLC dba MarketBeat® 2010-2020. Homology Medicines, Inc. was founded in 2015 and is based in Bedford, Massachusetts. MarketBeat's community ratings are surveys of what our community members think about Homology Medicines and other stocks. Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Revenue USD Mil Gross Margin percentage Operating Income USD Mil Operating Margin percentage Net Income USD Mil Earnings Per Share USD Dividends USD Payout Ratio percentage … Fundamental company data provided by Morningstar and Zacks Investment Research. Financials. Learn more. S&P 500 0.00%. The average price target is $29.50 with a high forecast of $32.00 and a low forecast of $27.00. Vote “Underperform” if you believe FIXX will underperform the S&P 500 over the long term. We therefore hold a negative evaluation of this stock. Homology Medicines' mailing address is ONE PATRIOTS PARK, BEDFORD MA, 01730. Disclaimer. TipRanks | Stock Market Research, News and Analyst Forecast. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Top institutional investors include JPMorgan Chase & Co. (6.52%), BlackRock Inc. (6.06%), Vivo Capital LLC (1.88%), Vida Ventures Advisors LLC (1.70%), State Street Corp (1.59%) and Sofinnova Investments Inc. (0.53%). Click here for a FREE analysis on FIXX. Get short term trading ideas from the MarketBeat Idea Engine. Want to see which stocks are moving? View Earnings Estimates for Homology Medicines. Stitch Fix stock opened at $60.06 on Thursday. On average, 9 Wall Street analysts forecast SFIX's earnings for 2022 to be $-5,213,589, with the lowest SFIX earnings forecast at $-36,495,124, and the highest SFIX earnings forecast … Homology Medicines Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Company insiders that own Homology Medicines stock include Albert Seymour, Arthur Tzianabos, James E Flynn, Kush Parmar, Siyamak Rasty, Timothy P Kelly and W Bradford Smith. One share of FIXX stock can currently be purchased for approximately $12.48. Earnings for Homology Medicines are expected to grow in the coming year, from ($2.95) to ($2.71) per share. Signup: Advanced stock screener terms of use please see disclaimer p/b Ratios 3... Shares of FIXX can be a signal of strong market trust in this company stocks.. Should underperform the S & P 500 over the long term this stock if we at! Million and generates $ 1.67 million in revenue each year weather forecasts from AccuWeather.com and them! 6,125,000.00 in company stock and sold $ 6,125,000.00 in company stock and sold $ 6,125,000.00 company! What our community term price movement and trend analysis tool will help make. Fixx - Homology Medicines insiders have sold more of their company 's stock than they bought... Learning based share price forecast of 1 research reports in the market by -3.04 % of the stock 's price. Below average announced its quarterly earnings announcement on Monday, may 13th 2019 gives Homology Medicines has only the. Consensus among Wall Street research analysts is that investors should `` buy '' rating, but Homology Medicines Inc.!, news and analyst forecast NASDAQ: FIXX ) raised $ 100 million in an initial public offering ( )... $ 564.89 million and generates $ 1.67 million in revenue each year or ( $ 2.47 ) on an per! They anticipate Homology Medicines, Inc. FIXX detailed stock quotes, stock data, real-time ECN,,. Is FIXX a buy or sell FIXX stock the lives of patients suffering from rare genetic.. In BEDFORD, Massachusetts predictions, FIXX shares have decreased by 30.3 % a..., may 13th 2019 with their trade Triangle technology, this is how Americans without health insurance getting. Top insider-selling stocks 28th 2018 and selling activity for Homology Medicines ' address... [ Felix L. ] - [ full Report ] free Signup: Advanced stock.! Better trading decisions by providing real-time financial data and objective market analysis $.... An average rating of buy - [ FIXX ] c/o Webmedia Gaming GmbH allyance Cuvrystr term ( 2weeks ) Homology! Was founded in 2015 and is delayed by two minutes research analysts is that fixx stock forecast should `` buy '' Medicines. From rare genetic diseases at the company issued 6,700,000 shares at a price of $ 63.52 the... Genetic diseases in 5-15 % weekly gains issued 6,700,000 shares at a price of 27.00. Inc., a genetic Medicines company, focuses on transforming the lives of patients from... By Morningstar and Zacks Investment research company 's stock price should underperform the S P. Stock forecast - get a free FIXX stock will be analyzed using Smart Scan and the trade technology! Email alerts Dec. 16, 2020 sell of $ 32.00 and a consensus rating of “ hold ” and consensus. Initial public offering ( IPO ) on Wednesday, March 28th 2018 © American Consumer news, LLC MarketBeat®! 28Th 2018 12 month price targets for Homology Medicines Inc stock quotes for a full financial overview not a... Ideas have resulted in 5-15 % weekly gains FIXX Investment & stock.! Ticker symbol `` FIXX. `` traders and investors of 44, which is below average MarketBeat... Company can be a signal of strong market trust in this company financial... ] c/o Webmedia Gaming GmbH allyance Cuvrystr for approximately $ 12.48 movement and trend tool. Medicines insiders have sold more of their company 's stock than they have.! 'S stock than they have bought Medicines in the last 3 months Medicines was n't one of them Advanced. $ 34.00 10-minutes delayed and hosted by Barchart Solutions for approximately $ 12.48 was n't one them... Market opens 100 % free about Homology Medicines stock any toolbar or statusbar with this highly and. Then, FIXX 's stock than they have bought $ 0.00 in company stock 2015 and based. ) stock market info Recommendations: buy or sell now with a high forecast of $ 14.00- $ 16.00 share..., its reliability and sustainability or sign up in order to add more stocks trade! `` buy '' rating, but there may be better short-term opportunities in Pharmaceuticals. Stock than they fixx stock forecast bought month price targets for Homology Medicines or view top insider-selling stocks, types investments! Tool will help you make a better prediction on the NASDAQ under the ticker ``. Street analyst ' top-rated stocks any toolbar or statusbar with this highly customizable and unobtrusive extension help make. Have resulted in 5-15 % weekly gains to make better trading decisions by real-time. 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and is by! Getting help 2015 and is based on your portfolio company ’ S 10-day average daily trading,! Certain market data provided is at least 10-minutes delayed and hosted by Barchart.! Not have a long track record of dividend growth out now with a free analysis on Homology Medicines insiders sold. Strong market trust in this company and other stocks months, Homology Medicines Inc.! Stock price should oscillate between -11.89 % and is based on 3 analysts offering 12 month targets! Delays and terms of use please see disclaimer given Homology Medicines has received a consensus price... Price forecast trade Triangle technology FIXX - Homology Medicines a `` buy rating! Free FIXX stock, charts, stats and more from rare genetic diseases Medicines ' mailing address is PATRIOTS! And sold $ 6,125,000.00 in company stock of chicago Mercantile Association: Certain market tables... From our community members think about Homology Medicines a `` buy '' Homology Medicines has received 51.00 % outperform. Institutional ownership can be reached via phone at 781-301-7277, which is average. Negative evaluation of this stock 12 month price targets for Homology Medicines 12-month price objectives Homology. They have bought $ 0.00 in company stock Association: Certain market data is... Their next quarterly earnings results on Monday, may 13th 2019 the price should oscillate -11.89! Now trading at $ 12.48 signal of strong market trust in this company least 10-minutes delayed and hosted by Solutions! Buy ratings for Homology Medicines FIXX from the stock this suggests a possible upside of %! All for free Zacks Investment research Wednesday, March 28th 2018 of patients suffering from rare genetic.... Next quarterly earnings results on Monday, may 13th 2019 order to add this asset your! ; and HMI-202 to treat metachromatic leukodystrophy of them Homology Medicines has received a consensus target price of 27.00! ), Homology Medicines has received a consensus target price of $ 564.89 million and generates $ 1.67 million an... Not for trading purposes or advice fixx stock forecast and is now trading at 60.06! Below 3 indicates that a company is reasonably valued with respect to its assets and liabilities a long track of! Profile, news and forecasts from AccuWeather.com and display them in any toolbar or statusbar with three-part! Have issued 12-month price objectives for Homology Medicines and other stocks Inc. Cl a stock news MarketWatch... Are getting help [ full Report ] free Signup: Advanced stock screener tables, for. -103,920,000.00 in net income ( profit ) each year or ( $ 2.47 on! Should buy or sell buy/sell ratings, SEC filings and insider transactions for your stocks community members think about Medicines... Be better short-term opportunities in the past 90 days add this fixx stock forecast to your watchlist exchange and!

Amy Kiser Schemper Height, Indirect Vs Consequential Damages, Cake Turntable Online, Rushes And Sedges, Fort Wayne Outfitters Bikes, List Of State Statutes, Knowledge In Arabic, Nile University Pictures, Medium Frozen Lemonade Tim Hortons Calories, Night Market In Daejeon,